adenosine monophosphate has been researched along with Hemorrhagic Thrombocythemia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Buono, A; De Blasio, G; Ielasi, A; Loffi, M; Tespili, M | 1 |
Kaplan, KL; Lages, BA; Rosove, MH; Weiss, HJ | 1 |
2 other study(ies) available for adenosine monophosphate and Hemorrhagic Thrombocythemia
Article | Year |
---|---|
Intracoronary cangrelor administration-assisted primary percutaneous coronary intervention in a patient with essential thrombocythemia and recurrent ST-segment elevation myocardial infarction.
Topics: Adenosine Monophosphate; Adult; Angioplasty, Balloon, Coronary; Coronary Thrombosis; Drug-Eluting Stents; Humans; Hydroxyurea; Infusions, Intravenous; Male; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Recurrence; ST Elevation Myocardial Infarction; Thrombocythemia, Essential; Treatment Outcome | 2020 |
Acquired storage pool deficiency with increased platelet-associated IgG. Report of five cases.
Topics: Adenosine Monophosphate; Adenosine Triphosphate; beta-Thromboglobulin; Blood Platelets; Calcium; Humans; Hypergammaglobulinemia; Immunoglobulin G; Lupus Erythematosus, Systemic; Platelet Aggregation; Purpura, Thrombocytopenic; Serotonin; Thrombocythemia, Essential | 1980 |